Utpal Koppikar

Companies

• C4 Therapeutics (United States)Board member Mar 17, 2022 to now¹
• Atara Biotherapeutics, Inc.Chief financial officer Jun 7, 2018 to Mar 6, 2023²
• Flexion TherapeuticsBoard member Jul 12, 2021 to Nov 19, 2021³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ABAtara Biotherapeutics, Inc. ATRA181,978 shares⁴$1.7M at $9.24Mar 2, 2023
• C4 Therapeutics (United States) CCCC5,667 shares⁵$16.3K at $2.88Feb 8, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 2, 2023Sold 6,871 shares at $3.63 of Atara Biotherapeutics, Inc.⁴
• Feb 8, 2023Bought 5,667 shares at $5.60 of C4 Therapeutics (United States)⁵
• Feb 7, 2023Sold 2,485 shares at $5.46 of Atara Biotherapeutics, Inc.⁶
• Nov 16, 2022Sold 1,083 shares at $4.49 of Atara Biotherapeutics, Inc.⁷
• Nov 16, 2022Sold 5,172 shares at $4.49 of Atara Biotherapeutics, Inc.⁷
• Aug 16, 2022Sold 5,940 shares at $5.04 of Atara Biotherapeutics, Inc.⁸
• Jun 8, 2022Sold 5,853 shares at $5.63 of Atara Biotherapeutics, Inc.⁹
• May 17, 2022Sold 966 shares at $5.32 of Atara Biotherapeutics, Inc.¹⁰
• May 17, 2022Sold 4,616 shares at $5.32 of Atara Biotherapeutics, Inc.¹⁰
• Mar 1, 2022Sold 1,491 shares at $9.86 of Atara Biotherapeutics, Inc.¹¹
• Mar 1, 2022Sold 2,272 shares at $9.86 of Atara Biotherapeutics, Inc.¹¹
• Mar 1, 2022Granted 61,235 shares of Atara Biotherapeutics, Inc.¹¹
• Feb 7, 2022Sold 2,496 shares at $14.46 of Atara Biotherapeutics, Inc.¹²
• Nov 16, 2021Sold 3,655 shares at $17.12 of Atara Biotherapeutics, Inc.¹³